Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04285853 · ClinicalTrials.gov registry record · Phase 4
Are Opioids Needed After ACL Reconstruction
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 98
- Enrollment target
NCT04285853 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 98 participants.
The verdict
NCT04285853, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 98 participants
- Enrollment target
Study Summary
As the public health sector continues to confront the opioid epidemic, orthopaedic surgeons must revisit pain management protocols to reduce unnecessary opioid prescriptions. The long-term goal is to reduce opioid use and residual opioids in circulation.
Interventions
- DRUG Oxycodone
- DRUG Placebo oral tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2020-09-16 |
| Est. Completion | 2022-09-19 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04285853
The ClinicalTrials.gov registry entry for NCT04285853 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oxycodone is the first listed.
NCT04285853 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04285853 about?
NCT04285853 is a clinical study titled "Are Opioids Needed After ACL Reconstruction". As the public health sector continues to confront the opioid epidemic, orthopaedic surgeons must revisit pain management protocols to reduce unnecessary opioid prescriptions. The long-term goal is to reduce opioid use and residual opioids in circulation.
What is the current status of trial NCT04285853?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 98 participants. The study started on 2020-09-16. Estimated completion is 2022-09-19.
What interventions are being tested in trial NCT04285853?
The interventions under investigation include: Oxycodone (DRUG), Placebo oral tablet (DRUG).
Who is sponsoring clinical trial NCT04285853?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.